Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.

@article{Bonnet2004FibratesOS,
  title={Fibrates or statins and lipid plasma levels in 245 patients treated with highly active antiretroviral therapy. Aquitaine Cohort, France, 1999-2001.},
  author={Fabrice Bonnet and Eric Balestre and Rodolphe Thi{\'e}baut and Patrick Merci{\'e} and Michel Dupon and P. Morlat and François Dabis},
  journal={HIV medicine},
  year={2004},
  volume={5 3},
  pages={133-9}
}
OBJECTIVES To describe the effect and tolerance of lipid-lowering drugs (LLD; fibrates and statins) in patients treated with highly active antiretroviral therapy (HAART). METHODS A prospective study was performed in a large cohort of HAART-treated HIV-infected patients using guidelines for case management of dyslipidaemia. Inclusion criteria were: age over 18 years; HIV infection treated with HAART including at least one protease inhibitor (PI) or nonnucleoside reverse transcriptase inhibitor… CONTINUE READING